New tool aims to help breast cancer patients choose treatment

NCT ID NCT06762496

Recruiting now Knowledge-focused Sponsor: European Institute of Oncology Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is developing and testing a printed decision aid for women diagnosed with early-stage breast cancer. The tool is designed to help them make informed choices about their treatment. Researchers will compare how well women who receive the aid feel about their decisions versus those who do not. The trial involves 180 participants and aims to improve patient engagement in healthcare.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Patient decision aid (PDA) - a printed tool to support treatment choices
What this could lead to: If successful, this tool could help women with early breast cancer feel more informed and involved in their treatment decisions.
What could go wrong: This is a small, early-stage study testing a support tool, not a treatment. It may not show clear benefits or apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE I are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER STAGE I BREAST CANCER STAGE II BREAST CARCINOMA

Contacts and locations

Locations

European Institute of Oncology
RECRUITING

Milan, Italy, 20141, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.